However, the hyperactive Nrf2 activity is also contrarily reconsidered as a potent oncogenic driver with those relevant hallmarks of cancer, because of its tumor-promoting effects exerted bona fide on carcinogenesis, cancer progression, metastasis, and even drug resistance to therapy 265, 412. The gene discussed is NFE2L2; the disease is cancer.